Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 4
1970 3
1971 2
1972 2
1973 4
1974 7
1975 11
1976 4
1977 8
1978 3
1979 3
1980 5
1981 8
1982 6
1983 6
1984 6
1985 4
1986 4
1987 3
1988 6
1989 5
1990 3
1991 5
1992 5
1993 3
1994 2
1995 3
2001 4
2003 5
2004 2
2005 2
2006 2
2007 1
2008 2
2009 9
2010 8
2011 8
2012 1
2014 2
2015 2
2016 5
2017 10
2018 7
2019 1
2020 4
2021 3
2022 5
2023 7
2024 3
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.
Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML; Retatrutide Phase 2 Obesity Trial Investigators. Jastreboff AM, et al. N Engl J Med. 2023 Aug 10;389(6):514-526. doi: 10.1056/NEJMoa2301972. Epub 2023 Jun 26. N Engl J Med. 2023. PMID: 37366315 Clinical Trial.
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.
Freeman MW, Halvorsen YD, Marshall W, Pater M, Isaacsohn J, Pearce C, Murphy B, Alp N, Srivastava A, Bhatt DL, Brown MJ; BrigHTN Investigators. Freeman MW, et al. N Engl J Med. 2023 Feb 2;388(5):395-405. doi: 10.1056/NEJMoa2213169. Epub 2022 Nov 7. N Engl J Med. 2023. PMID: 36342143 Clinical Trial.
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.
Laffin LJ, Kopjar B, Melgaard C, Wolski K, Ibbitson J, Bhikam S, Weir MR, Ofili EO, Mehra R, Luther JM, Cohen DL, Sarraju A, Wilkinson MJ, Flack JM, Rodman D, Nissen SE; Advance-HTN Investigators. Laffin LJ, et al. N Engl J Med. 2025 May 8;392(18):1813-1823. doi: 10.1056/NEJMoa2501440. Epub 2025 Apr 23. N Engl J Med. 2025. PMID: 40267417 Clinical Trial.
Placental toxicology.
Goodman DR, James RC, Harbison RD. Goodman DR, et al. Among authors: harbison rd. Food Chem Toxicol. 1982 Feb;20(1):123-8. doi: 10.1016/s0278-6915(82)80018-5. Food Chem Toxicol. 1982. PMID: 7040181 Review.
Rubratoxins.
Wilson BJ, Harbison RD. Wilson BJ, et al. Among authors: harbison rd. J Am Vet Med Assoc. 1973 Dec 1;163(11):1274-6. J Am Vet Med Assoc. 1973. PMID: 4593856 Free article. Review. No abstract available.
220 results